Metformin is one of the most frequently and effectively prescribed treatments for Type 2 diabetes, helping to lower blood sugar and enhance insulin sensitivity while simultaneously prolonging lifespan and healthspan of nematode worms and rodents.
Recent studies have uncovered various molecular mechanisms by which metformin extends animal lifespan. These include activating AMPK, stimulating autophagy and mitigating inflammation linked to cell senescence.
Epigenetics
Metformin, as one of the world’s primary treatments for type 2 diabetes, has demonstrated substantial anti-aging potential beyond its glycemic benefits. Numerous studies using different cell and animal models have demonstrated how metformin affects fundamental cellular processes such as energy regulation, inflammation, autophagy and genomic stability to delay aging while mitigating age-related diseases.
Epigenetics – the study of how gene expression patterns are controlled without changing DNA sequence – plays an integral part in physiological aging and homeostasis. When epigenetic factors become disrupted, dramatic consequences such as chronic inflammation, fibrosis, and cancer may follow; Metformin has been found to regulate this chromatin remodeling process, mitigating some of these detrimental side effects.
Metformin inhibits activation of AMPK-mTOR pathways that are key regulators of energy balance, metabolism, and growth within cells. Furthermore, metformin promotes autophagy – an essential process that degrades damaged and stalled proteins while providing metabolic building blocks – a study demonstrated this with mice overexpressing Atg5 gene product; an essential component of autophagosome. Upon treatment with metformin cells exhibit higher levels of P22phox protease protection while decreasing expression of pro-inflammatory NF-kB pro-inflammatory pro-inflammatory pro-inflammatory pro-inflammatory pro-inflammatory pro-kB and pro-apoptotic Bax proinflammatory pro-inflammatory pro-inflammatory pro-inflammatory pro-inflammatory pro-inflammatory pro-inflammatory pro-inflammatory pro-kB as well as pro-apoptotic Bax.
Metformin has also been shown to reduce expression of genes linked to aging in human fibroblasts, supporting the theory that metformin may serve as an epigenetic modulator that slows aging by altering chromatin modifications and reprogramming genes to their normal state.
Metformin has also been shown to reverse hyperglycemic memory in endothelial cells (BRECs). High glucose uncouples eNOS, leading to an increase in monomeric rather than dimeric expression of eNOS and increasing levels of oxidative stress via NADPH oxidase and COX-2 expression; metformin can intervene by increasing SIRT1 expression while simultaneously decreasing ROS accumulation; this prevents an increase in NF-kB and Bax expression and hyperglycemic stress-induced apoptosis (193).
Although research on metformin is encouraging, some caution must be exercised when taking this medication. Please consult a doctor prior to using this medicine if you have preexisting medical conditions such as heart disease or kidney problems; alcohol or smoking while on metformin could worsen conditions further.
Mitochondrial Health
Your cells’ mitochondria are tiny organelles responsible for producing most of the energy your body requires to survive and thrive, as well as playing key roles in other essential cellular processes. As researchers uncover more details about this form of energy production, insights about it may lead to novel methods of treating disease.
Mitochondria are unique among organelles in that they contain their own genome consisting of 37 genes. You inherit these from your mother’s egg cell and they can pass from parent to parent either autosomally dominantly or recessively, passing down mitochondrial diseases when these mutated genes lead to cells losing the ability to generate energy, leading to symptoms in different parts of the body and sometimes mild to severe consequences; some types may even prove fatal.
Numerous factors can damage mitochondria, including viruses, toxins and age. When mitochondria are damaged they cannot produce enough energy for cells to function normally and start breaking down and losing function – particularly damaging for muscles and nerves as these need a great deal of energy to function normally. Mitochondrial diseases may manifest themselves through muscle weakness, lack of energy and symptoms such as an ongoing sense of illness.
Researchers have observed that metformin can reduce physiological aging in animal models such as worms, fruit flies, and rodents. Studies also demonstrated that metformin extends healthspan in thymic atrophy by improving mitochondrial function while decreasing inflammation and oxidative stress levels; furthermore it mitigates cellular senescence by upregulating Sirtuin 1 activity and decreasing NLR Family CARD Domain Containing 4 (NLRC4) phosphorylation phosphorylation rates.
Picard and his team have begun exploring whether similar molecular mechanisms that delay aging in animals exist in humans. To do this, they are recruiting both people with mitochondrial diseases as well as healthy volunteers for long-term cellular imaging, blood tests, and questionnaires to provide data that will allow them to study how the aging process differs between these groups and whether metformin might reverse it.
Metabolic Health
Researchers are actively engaged in finding strategies to delay human aging and prolong lifespans. While various anti-ageing interventions have shown promising results, metformin is among the most promising. As it’s cheap, safe, and widely available, its efficacy has been verified in animal models such as nematode worms, fruit flies, rodents as well as mitigating neuroinflammation, slow cancer growth and improving vascular function – metformin can make an outstanding addition to an anti-ageing strategy
Metformin’s ability to reverse aging lies in its ability to correct metabolic imbalances and enhance mitochondrial function and epigenetic regulation, promote gut microbiota health and enhance cellular redox homeostasis; reduce production of pro-inflammatory cytokines while modulating host inflammatory pathways; this makes metformin an effective treatment option for neuroinflammation, cognitive decline and cardiovascular disease – among many other conditions associated with aging.
Many cellular mechanisms that contribute to the aging process involve energy metabolism and nutrient sensing. Insulin/insulin-like growth factor (IGF) and mechanistic target of rapamycin (mTOR) signaling pathways are essential in controlling energy metabolism, protein turnover and cell proliferation; therefore Metformin can act as an inhibitor of both IGF-1 and mTOR to decrease stress levels and slow aging processes.
Metformin can also fight aging through its ability to promote brown adipose tissue (BAT) activation and energy expenditure by activating the AMPK pathway and increasing heat generation, improving BAT functionality and fat oxidation. Furthermore, metformin increases stem cells within BAT to prevent their senescence or dysfunction during fat metabolism.
Metformin can significantly decrease senescent macrophage numbers and suppress NLR Family CARD Domain Containing 4 (NLRC4) phosphorylation in humans, providing another step in improving human longevity. Although more research needs to be conducted into how metformin works to extend both lifespan and healthspan.
Cognitive Health
Cognitive health refers to our ability to think, learn and remember clearly. Genes, environment and lifestyle all influence cognitive wellbeing – though normal forgetfulness as we age should not indicate more serious problems such as dementia or mild cognitive impairment (MCI).
Communication with your doctor regarding mental health concerns is of utmost importance. Engaging in regular cognitive screenings at checkups is one way of early detection and providing tools for dealing with any decline. Beyond screenings, patients need to be educated about ways they can keep themselves mentally healthy by practicing positive thinking, letting go of grudges, and appreciating simple pleasures like sipping tea or witnessing sunrise.
Scientists are developing a test to detect Alzheimer’s disease and other forms of dementia in people without diabetes or insulin resistance. Research suggests that controlling this resistance with Metformin may significantly lower the risk of such disorders – especially among people aged 60+.
Recent research showed that taking low doses of the relatively inexpensive diabetes drug metformin preserved cognition and postponed brain deterioration in mice with Alzheimer’s disease. Researchers found that metformin helped slow symptoms’ onset as well as prevent brain cell damage by targeting an important protein known as mTOR which promotes cell growth.
Humans’ mTOR pathway can become activated by environmental stressors like high blood sugar levels or chronic inflammation, and overactivation increases the risk of cancer and neurodegeneration. A daily dose of metformin inhibits this overactivation and slows cell aging.
Researchers believe metformin may reverse aging by decreasing production of harmful reactive oxygen species, encouraging DNA repair, improving mitochondrial function and decreasing chronic inflammation. Furthermore, researchers are testing whether metformin can also delay Alzheimer’s and other brain diseases by suppressing formation of beta amyloid plaques that serve as markers of Alzheimer’s. If successful, this approach could transform how we treat and prevent age-related conditions; TAME (Treatment of Advancing MICE) Trial will become the first clinical trial evaluating Metformin’s anti-ageing effects among an extensive population of non-diabetic older adults – making history!
